Inhibitory effects of calcium channel blockers on thyroid hormone uptake in neonatal rat cardiomyocytes

Authors:

Abstract
The effects of the Ca2+channel blockers verapamil, nifedipine, and diltiazem on triiodothyronine (T3) and thyroxine (T4) uptake were tested in cultured cardiomyocytes from 2-day-old rats. Experiments were performed at 37°C in medium with 0.5% BSA for [125I]T3(100 pM) or 0.1% BSA for [125I]T4(350 pM). The 15-min uptake of [125I]T3was 0.124 ± 0.013 fmol/pM free T3( n = 6); [125I]T4uptake was 0.032 ± 0.003 fmol/pM free T4( n = 12). Neither T3nor T4uptake was affected by 1% DMSO (diluent for nifedipine and verapamil). Uptake of [125I]T3but not of [125I]T4was dose dependently reduced by incubation with 1–100 μM verapamil (49–87%, P < 0.05) or nifedipine (53–81%, P < 0.05). The relative decline in [125I]T3uptake after 4 h of incubation with 10 μM verapamil or nifedipine was less than after 15 min or 1 h, indicating that the major inhibitory effect of the Ca2+channel blockers occurred at the level of the plasma membrane. The reduction of nuclear [125I]T3binding by 10 μM verapamil or nifedipine was proportional to the reduction of cellular [125I]T3uptake. Diltiazem (1–100 μM) had no dose-dependent effect on [125I]T3uptake but reduced [125I]T4uptake by 45% ( P < 0.05) at each concentration tested. Neither the presence of 20 mM K+nor the presence of low Ca2+in the medium affected [125I]T3uptake. In conclusion, the inhibitory effects of Ca2+channel blockers on T3uptake in cardiomyocytes are not secondary to their effects on Ca2+influx but, rather, reflect interference with the putative T3carrier in the plasma membrane.

This publication has 34 references indexed in Scilit: